Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats

[1]  A. Kakita,et al.  Prefrontal Abnormality of Schizophrenia Revealed by DNA Microarray: Impact on Glial and Neurotrophic Gene Expression , 2004, Annals of the New York Academy of Sciences.

[2]  Limin Shi,et al.  Prenatal Viral Infection Leads to Pyramidal Cell Atrophy and Macrocephaly in Adulthood: Implications for Genesis of Autism and Schizophrenia , 2002, Cellular and Molecular Neurobiology.

[3]  M. Iyo,et al.  A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients , 2003, Neuroscience Research.

[4]  Limin Shi,et al.  Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring , 2003, The Journal of Neuroscience.

[5]  A. Kakita,et al.  Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development , 2003, Molecular Psychiatry.

[6]  M. Satoh,et al.  Kainic acid induces leukemia inhibitory factor mRNA expression in the rat brain: differences in the time course of mRNA expression between the dentate gyrus and hippocampal CA1/CA3 subfields. , 2002, Brain research. Molecular brain research.

[7]  R. Fields,et al.  New insights into neuron-glia communication. , 2002, Science.

[8]  G. Rajkowska,et al.  Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia , 2002, Schizophrenia Research.

[9]  T. Sigmundsson,et al.  Brain anatomy and sensorimotor gating in Asperger's syndrome. , 2002, Brain : a journal of neurology.

[10]  Helmut Butzkueven,et al.  LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival , 2002, Nature Medicine.

[11]  R. Pioli,et al.  Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor , 2002, Schizophrenia Research.

[12]  S. Itohara,et al.  Glial protein S100B modulates long-term neuronal synaptic plasticity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Eric Gershwin,et al.  Genetic and Immunologic Considerations in Autism , 2002, Neurobiology of Disease.

[14]  R. Dantzer,et al.  Cytokine-induced sickness behaviour: mechanisms and implications , 2002, Trends in Neurosciences.

[15]  P. Patterson,et al.  Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness , 2002, Current Opinion in Neurobiology.

[16]  J. Borrell,et al.  Prenatal Immune Challenge Disrupts Sensorimotor Gating in Adult Rats: Implications for the Etiopathogenesis of Schizophrenia , 2002, Neuropsychopharmacology.

[17]  S. Weiss,et al.  The Ciliary Neurotrophic Factor/Leukemia Inhibitory Factor/gp130 Receptor Complex Operates in the Maintenance of Mammalian Forebrain Neural Stem Cells , 2001, The Journal of Neuroscience.

[18]  R. Saunders,et al.  A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis , 2001, Brain Research Bulletin.

[19]  S. Zalcman.  Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity , 2001, Brain Research.

[20]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A K Manatunga,et al.  Paroxetine for the prevention of depression induced by high-dose interferon alfa. , 2001, The New England journal of medicine.

[22]  R. Dantzer.  Cytokine‐Induced Sickness Behavior: Mechanisms and Implications , 2001, Annals of the New York Academy of Sciences.

[23]  D. Riche,et al.  Ciliary Neurotrophic Factor May Activate Mature Astrocytes via Binding with the Leukemia Inhibitory Factor Receptor , 2001, Molecular and Cellular Neuroscience.

[24]  B. Barres,et al.  Control of synapse number by glia. , 2001, Science.

[25]  J. Lieberman,et al.  Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain , 2001, Schizophrenia Research.

[26]  Harumi Jyonouchi,et al.  Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression , 2001, Journal of Neuroimmunology.

[27]  V. Arolt,et al.  Different immune patterns in melancholic and non-melancholic major depression , 2001, European Archives of Psychiatry and Clinical Neuroscience.

[28]  A. Kastin,et al.  Passage of Interleukin-1-Beta Across the Blood-Brain Barrier Is Reduced in Aged Mice: A Possible Mechanism for Diminished Fever in Aging , 2000, Neuroimmunomodulation.

[29]  S. Melmed,et al.  Leukemia Inhibitory Factor Mediates the Hypothalamic Pituitary Adrenal Axis Response to Inflammation* * This work was supported by NIDDK Grants DK-54862-02 (to V.C.) and 501238 (to S.M.) and the Doris Factor Molecular Endocrinology Laboratory. , 2000, Endocrinology.

[30]  T. Nabeshima,et al.  Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-α gene: implications for emotional behavior , 2000, Journal of Neuroimmunology.

[31]  H Nawa,et al.  Cytokine and growth factor involvement in schizophrenia—support for the developmental model , 2000, Molecular Psychiatry.

[32]  M. A. Hebert,et al.  Protein Phosphorylation Cascades Associated with Methamphetamine‐induced Glial Activation , 2000, Annals of the New York Academy of Sciences.

[33]  W. Pan,et al.  Saturable entry of leukemia inhibitory factor from blood to the central nervous system , 2000, Journal of Neuroimmunology.

[34]  M. Makino,et al.  Involvement of central opioid systems in human interferon‐α induced immobility in the mouse forced swimming test , 2000, British journal of pharmacology.

[35]  N. Swerdlow,et al.  Toward Understanding the Biology of a Complex Phenotype: Rat Strain and Substrain Differences in the Sensorimotor Gating-Disruptive Effects of Dopamine Agonists , 2000, The Journal of Neuroscience.

[36]  Jing Han,et al.  Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro , 2000, The European journal of neuroscience.

[37]  E. Bosmans,et al.  Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms , 2000, Psychoneuroendocrinology.

[38]  R. Yolken,et al.  Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.

[39]  W. Lipkin,et al.  An infection-based model of neurodevelopmental damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Patterson,et al.  Cytokine and Growth Factor Involvement in Long-Term Potentiation , 1999, Molecular and Cellular Neuroscience.

[41]  K. Akiyama.  Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration , 1999, Schizophrenia Research.

[42]  R. Pioli,et al.  The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 , 1998, Schizophrenia Research.

[43]  C. Ware,et al.  Neural precursor differentiation into astrocytes requires signaling through the leukemia inhibitory factor receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Isohanni,et al.  Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. , 1998, The American journal of psychiatry.

[45]  M. Ackenheil,et al.  Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[46]  M A Geyer,et al.  Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. , 1998, Schizophrenia bulletin.

[47]  M. Greenberg,et al.  Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. , 1997, Science.

[48]  J. Rapoport,et al.  Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. , 1997, Journal of immunology.

[49]  P. Patterson,et al.  Leukemia Inhibitory Factor Is Expressed in Astrocytes Following Cortical Brain Injury , 1997, Experimental Neurology.

[50]  T. Kishimoto,et al.  Gp130 and the interleukin-6 family of cytokines. , 1997, Annual review of immunology.

[51]  Richard F. Thompson,et al.  Deficient Cerebellar Long-Term Depression, Impaired Eyeblink Conditioning, and Normal Motor Coordination in GFAP Mutant Mice , 1996, Neuron.

[52]  Mark Hallett,et al.  Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results , 1996, Biological Psychiatry.

[53]  P. Salmi,et al.  A new computer-assisted two-way avoidance conditioning equipment for rats: behavioral and pharmacological validation. , 1994, Journal of pharmacological and toxicological methods.

[54]  E. Murray,et al.  Cytopathologic and Neurochemical Correlates of Progression to Motor/Cognitive Impairment in SIV-lnfected Rhesus Monkeys , 1994, Journal of neuropathology and experimental neurology.

[55]  J. Krystal,et al.  Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. , 1993, The American journal of psychiatry.

[56]  E. O'callaghan,et al.  Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. , 1992 .

[57]  J. Martinou,et al.  Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic motoneurons in vitro , 1992, Neuron.

[58]  H. Steinberg.  Erythropoietin and visual hallucinations. , 1991, The New England journal of medicine.

[59]  D L Braff,et al.  Sensorimotor gating and schizophrenia. Human and animal model studies. , 1990, Archives of general psychiatry.

[60]  R. Aebersold,et al.  The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. , 1989, Science.

[61]  H. Thomas,et al.  INTERFERONS AS MEDIATORS OF PSYCHIATRIC MORBIDITY An Investigation in a Trial of Recombinant α-Interferon in Hepatitis-B Carriers , 1987, The Lancet.

[62]  D. Rubinow,et al.  The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. , 1987, Annals of internal medicine.

[63]  K. Fukada.  Hormonal control of neurotransmitter choice in sympathetic neurone cultures , 1980, Nature.